SEARCH Articles Figures Tables Activity against human immunodeficiency virus Anti-Human immunodeficiency virus Anti-Human immunodeficiency virus HIV) activity Anti-Human immunodeficiency virus of antiarone Anti-Human immunodeficiency virus of broussoflavonol Anti-Human immunodeficiency virus of gancaonin Anti-Human immunodeficiency virus of glyasperin Anti-Human immunodeficiency virus of licochalcone Anti-Human immunodeficiency virus of mulberry tree Anti-Human immunodeficiency virus of norartocarpetin Anti-human immunodeficiency virus activity Anti-human immunodeficiency virus agent Cultivation human viruses Dementia human immunodeficiency virus-related Enzyme inhibitors human immunodeficiency virus protease Epstein-Barr virus human Future Anti-Human Immunodeficiency Virus Drugs Under Development Human Herpes virus Human Immune Deficiency Virus Human Immunodeficiency Virus and Disease Human Immunodeficiency Virus viral chemokines Human Immunodeficiency viruse Human Immunosuppressive Virus Human T-cell leukemia virus Human T-cell leukemia virus type I (HTLV Human T-cell lymphotrophic virus Human T-cell lymphotrophic virus type Human T-cell lymphotropic viruses Human T-lymphotropic virus Human T-lymphotropic virus type Human deficiency virus Human herpes virus 8 (HHV Human herpesvirus-8 virus Human immuno deficiency virus Human immunodeficiency virus Human immunodeficiency virus (HIV Human immunodeficiency virus (HIV protease inhibitors Human immunodeficiency virus (HIV vaccines Human immunodeficiency virus , and Human immunodeficiency virus -protease inhibitor Human immunodeficiency virus Cytomegalovirus Human immunodeficiency virus HAART Human immunodeficiency virus HAART therapy Human immunodeficiency virus HIV) infection Human immunodeficiency virus abacavir Human immunodeficiency virus about Human immunodeficiency virus absorption, distribution, and Human immunodeficiency virus action Human immunodeficiency virus adverse effects Human immunodeficiency virus amprenavir Human immunodeficiency virus and AIDS Human immunodeficiency virus assay Human immunodeficiency virus atazanavir Human immunodeficiency virus cells Human immunodeficiency virus central nervous system expression Human immunodeficiency virus chemistry Human immunodeficiency virus chemokine coreceptors Human immunodeficiency virus chemokine receptors Human immunodeficiency virus cleavage sites Human immunodeficiency virus combination therapy, AIDS Human immunodeficiency virus complex infection Human immunodeficiency virus compounds Human immunodeficiency virus conformational changes Human immunodeficiency virus cysteines Human immunodeficiency virus delavirdine Human immunodeficiency virus dendritic cells Human immunodeficiency virus detection Human immunodeficiency virus development Human immunodeficiency virus development into AIDS Human immunodeficiency virus discovery Human immunodeficiency virus drug development Human immunodeficiency virus drug resistance Human immunodeficiency virus drug-resistant strains Human immunodeficiency virus drugs targeting Human immunodeficiency virus early phase Human immunodeficiency virus efavirenz Human immunodeficiency virus emtricitabine Human immunodeficiency virus encephalitis Human immunodeficiency virus encephalopathies Human immunodeficiency virus enfuvirtide Human immunodeficiency virus entry inhibitors Human immunodeficiency virus enzyme inhibition Human immunodeficiency virus evidence Human immunodeficiency virus excretion Human immunodeficiency virus flexibility Human immunodeficiency virus hormone Human immunodeficiency virus identification Human immunodeficiency virus incidence Human immunodeficiency virus indinavir Human immunodeficiency virus infected cells Human immunodeficiency virus infection Human immunodeficiency virus infection development Human immunodeficiency virus infection drug resistance Human immunodeficiency virus infection immune system Human immunodeficiency virus infection mechanisms Human immunodeficiency virus infection resistance Human immunodeficiency virus infection treatment Human immunodeficiency virus infection, dementia Human immunodeficiency virus influenza vaccine Human immunodeficiency virus inhibition Human immunodeficiency virus inhibitors Human immunodeficiency virus initiation Human immunodeficiency virus injuries Human immunodeficiency virus interactions Human immunodeficiency virus isolation Human immunodeficiency virus lamivudine Human immunodeficiency virus lopinavir Human immunodeficiency virus lymph nodes Human immunodeficiency virus mechanisms of action Human immunodeficiency virus monocyte Human immunodeficiency virus monocyte-derived macrophages Human immunodeficiency virus mutation analysis Human immunodeficiency virus nelfinavir Human immunodeficiency virus neurocognitive impairment Human immunodeficiency virus neurodegeneration Human immunodeficiency virus neuropathy Human immunodeficiency virus nevirapine Human immunodeficiency virus nonnucleoside reverse Human immunodeficiency virus opportunistic infections Human immunodeficiency virus pathogenesis Human immunodeficiency virus pharmacokinetics Human immunodeficiency virus preparations Human immunodeficiency virus principles Human immunodeficiency virus progression Human immunodeficiency virus protease Human immunodeficiency virus protease design Human immunodeficiency virus protease nonpeptidic Human immunodeficiency virus protease peptidomimetic Human immunodeficiency virus receptor Human immunodeficiency virus replication Human immunodeficiency virus resistance Human immunodeficiency virus resistance mechanism Human immunodeficiency virus resistance testing Human immunodeficiency virus retrovirus Human immunodeficiency virus reverse Human immunodeficiency virus reverse inhibitor) Human immunodeficiency virus reverse transcriptase Human immunodeficiency virus reverse transcriptase HIV-RT) Human immunodeficiency virus reverse transcriptase inhibitors Human immunodeficiency virus ritonavir Human immunodeficiency virus saquinavir Human immunodeficiency virus specific agents Human immunodeficiency virus specific tissues Human immunodeficiency virus stavudine Human immunodeficiency virus structure Human immunodeficiency virus syndrome Human immunodeficiency virus tenofovir Human immunodeficiency virus therapeutic targets Human immunodeficiency virus tipranavir Human immunodeficiency virus transfer Human immunodeficiency virus transmission Human immunodeficiency virus treatment Human immunodeficiency virus type Human immunodeficiency virus type 1 (HIV Human immunodeficiency virus type 1 integrase Human immunodeficiency virus type 2, distribution Human immunodeficiency virus type examples Human immunodeficiency virus type isolation Human immunodeficiency virus type members Human immunodeficiency virus type probing Human immunodeficiency virus type source Human immunodeficiency virus types 1 and Human immunodeficiency virus vaccines Human immunodeficiency virus viral genome Human immunodeficiency virus viral life cycle Human immunodeficiency virus viral structure Human immunodeficiency virus zidovudine Human immunodeficiency virus, cytoplasmic Human immunodeficiency virus, drugs active against Human immunodeficiency virus-associated dementia Human immunodeficiency virus-associated dementia chemokines Human immunodeficiency virus. See Human immunodeficiency viruses 1 and 2 (HIV Human immunodefidency virus type Human influenza virus Human neurotropic virus Human papilloma virus Human papilloma virus HPV) vaccine Human papilloma virus carcinoma Human papilloma virus cervical cancer, cause Human papilloma virus humans Human papilloma virus infection Human papilloma virus type Human papilloma virus type microbicidal compound agains Human papilloma virus vaccine Human parainfluenza viruses Human polyoma virus Human respiratory syncytial virus Human simian virus 1 vaccine Infant human immunodeficiency virus infection Interferon in human immunodeficiency virus-related dementia Interleukin in human immunodeficiency virus-related dementia KSHV (human herpes virus Mononuclear phagocytes human immunodeficiency virus-infected Phenotyping of human immunodeficiency virus Proteinase, human immunodeficiency virus Selectivity for Influenza Virus Sialidase over Human Sialidases Simian-human immunodeficiency virus Simian-human immunodeficiency virus SHIV) Study Human Immunodeficiency Virus-1 Protease Inhibitors Virus human cytomegalovirus Virus human rhino- Viruses human immunodeficiency virus